The Potential Role for GLP-1 Agonists in Asthma Treatment
About this episode
The episode discusses the potential role of GLP-1 agonists in improving asthma control and reducing airway inflammation.
GLP-1 agonists have been blockbuster medications in diabetes and obesity but they may also have a surprising role in the treatment of asthma. Join the conversation as Katherine Cahill, MD, FAAAAI, discusses how GLP-1 agonists may improve asthma control and reduce airway inflammation. Find out more about asthma.
People in this episode
Guest: Katherine Cahill, MD, FAAAAI
Topics covered
- GLP-1 agonists
- asthma treatment
- airway inflammation
- diabetes
- obesity
- asthma control
Mentioned in this episode
Organizations: American Academy of Allergy, Asthma & Immunology
Products: GLP-1 agonists
More episodes of AAAAI Podcast: Conversations from the World of Allergy
- The Safety Signal: Building a Just Culture in Allergy and Immunology
- The Chef’s Table: Culinary Advice for Food Allergy Safety Chef Ming Tsai
- Breathing in Change: Allergies, Asthma, Immunology and a Warming Planet
- From Mentorship to Impact: Advancing Education, Research and Advocacy in Allergy & Immunology
- Alpha-Gal Syndrome: From Tick Bite to Anaphylaxis, Clinical Pearls and Unanswered Questions
- Boosting our Vaccine Knowledge: Updates, Allergy and Special Populations
Explore listener stats, chart rankings, contacts and more on the AAAAI Podcast: Conversations from the World of Allergy podcast page.